Repros Therapeutics (RPRX) is a development stage biopharmaceutical company. It is focused on the development of new drugs to treat hormonal and reproductive system disorders. This stock is trading up 14% at $4.77 in recent trading.
Today's Range: $4.45-$4.8552-Week Range: $3.34-$6.74 Volume: 655,000 Three-Month Average Volume: 67,613 Shares of RPRX are ripping higher today after the company announced on Wednesday that it has held a meeting with the Division of Reproductive and Urologic Products or DRUP to agree upon the registration requirements for the company's Androxal oral therapy for the treatment of secondary hypogonadism. >>7 Stocks Soaring in a Weak Market From a technical perspective, RPRX is gapping up sharply higher here on monster volume. This move has pushed RPRX back above both its 50-day and 200-day moving averages. It's also pushed RPRX into breakout territory since the stock has moved above some near-term overhead resistance at $4.50 to $4.70. Traders should continue to look for long-biased trades as long as RPRX is trending above $4.50 to $4.70 with strong upside volume flows, and if the stock can manage to close near or above its daily high of $4.90. If we continue to see that price action, then RPRX has a great chance of tagging its 2012 high of $5.36.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV